PRN: Research and Markets - Global Radiofrequency Ablation Market to Grow at a CAGR of 8.78%, 2017-2021 with AngioDynamics, Boston Scientific, Medtronic, St. Jude Medical & Stryker Dominating

27/apr/2017 00:30:12 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Research and Markets - Global Radiofrequency Ablation Market to Grow at a CAGR of 8.78%, 2017-2021 with AngioDynamics, Boston Scientific, Medtronic, St. Jude Medical & Stryker Dominating

 
[26-April-2017]
 

DUBLIN, Apr. 26, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Radiofrequency Ablation Market 2017-2021" report to their offering.

Research and Markets Logo

The global radiofrequency ablation market to grow at a CAGR of 8.78% during the period 2017-2021.

The report, Global Radiofrequency Ablation Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

The latest trend gaining momentum in the market is new product launches coupled with R&D activities. Vendors are increasingly focusing on the development and launch of new radiofrequency ablation devices. Product launches and R&D activities will help vendors survive in the market and enhance their growth. Vendors such as Medtronic, Boston Scientific, AngioDynamics, and Merit Medical Systems are actively involved in the development of innovative devices for improving the efficacy of radiofrequency ablation procedures.

According to the report, one of the major drivers for this market is increasing incidence of chronic disorders and growing older population. A sedentary lifestyle can negatively affect the homeostasis of the body. The dietary habits of people worldwide are changing, which make them susceptible to many disorders such as cardiovascular diseases, respiratory diseases, obesity, cancer, urology disorders, joint pain, Alzheimer's disease, and other chronic illnesses. According to the CDC data, the number of people with chronic disorders has been increasing steadily over the past two decades. So, the emphasis and focus on treatments for these diseases such as radiofrequency ablation have increased. Radiofrequency ablation devices are increasingly used to treat chest pain, joint pain, gynecological conditions, and liver and kidney problems.

Key vendors

  • AngioDynamics
  • Boston Scientific
  • Medtronic
  • St. Jude Medical
  • Stryker

Other prominent vendors

  • Accuray
  • Advanced Cardiac Therapeutics
  • APT Medical
  • Arthrex
  • AtriCure
  • Biosense Webster
  • BIOTRONIK
  • Bovie Medical
  • CardioFocus
  • Others

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by product

PART 07: Market segmentation by application

PART 08: Market segmentation by end-user

PART 09: Geographical segmentation

PART 10: Decision framework

PART 11: Drivers and challenges

PART 12: Market trends

PART 13: Vendor landscape

PART 14: Key vendor analysis

PART 15: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/vz2zsr/global

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl